GNR-069

BIOLOGICAL2 trials

Sponsors

AO GENERIUM

Conditions

Idiopathic Thrombocytopenic Purpura

Phase 3

Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP

CompletedNCT05220878

AO GENERIUMIdiopathic Thrombocytopenic Purpura

Start: 2021-09-09End: 2023-10-19Updated: 2024-03-06

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

CompletedNCT05492409

AO GENERIUMIdiopathic Thrombocytopenic Purpura

Start: 2022-03-28End: 2024-04-03Updated: 2024-06-21